Portage Biotech Inc. Files April 2024 6-K Report

Ticker: ATON · Form: 6-K · Filed: Apr 12, 2024 · CIK: 1095435

Portage Biotech INC. 6-K Filing Summary
FieldDetail
CompanyPortage Biotech INC. (ATON)
Form Type6-K
Filed DateApr 12, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

TL;DR

Portage Biotech Inc. filed its April 6-K, standard foreign private issuer update.

AI Summary

Portage Biotech Inc. filed a Form 6-K on April 12, 2024, reporting for the month of April 2024. The company, incorporated in the British Virgin Islands, is a pharmaceutical preparations company. Its principal executive office is located in Tortola, British Virgin Islands, with a contact person at Portage Development Services Inc. in Westport, Connecticut.

Why It Matters

This filing provides routine updates for investors regarding Portage Biotech Inc.'s ongoing operations and reporting status as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that does not appear to contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes public in its home country, or that is required to be made public by foreign stock exchanges, or that is distributed to its security holders.

When was Portage Biotech Inc. incorporated?

Portage Biotech Inc. is incorporated in the British Virgin Islands.

What is the SIC code for Portage Biotech Inc.?

The Standard Industrial Classification (SIC) code for Portage Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Who is the contact person for Portage Biotech Inc. in the US?

The contact person listed is Ian Walters at Portage Development Services Inc., located at 61 Wilton Road, Westport, Connecticut 06880.

Does Portage Biotech Inc. file annual reports on Form 20-F?

Yes, the filing indicates by check mark that the registrant files or will file annual reports under cover of Form 20-F.

Filing Stats: 269 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-04-12 17:21:12

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Portage Biotech Inc. (Registrant) Date: April 12, 2024 /s/ Allan Shaw Allan Shaw Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing